nygazet.com logo
Eli Lilly posts full trial data for obesity pill (LLY:NYSE)
business

Eli Lilly posts full trial data for obesity pill (LLY:NYSE)

1 min read

Eli Lilly (LLY) stock is in focus as the company posts detailed data from a late-stage trial for its obesity pill orforglipron at a European medical event. Read more here.

Eli Lilly posts detailed results from ATTAIN-1 late-stage trial for obesity pill Sep. 17, 2025 7:07 AM ETEli Lilly and Company (LLY) StockNVO, NONOFBy: Dulan Lokuwithana, SA News Editor Comments (6) Eli Lilly (NYSE:LLY) on Wednesday posted detailed d... [444 chars]

Read Original Article

Source: Seeking Alpha

Visit Source

Share this article